Journal article

OAB-001: Overall survival and progression-free survival by treatment duration with Daratumumab Lenalidomide/Dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: phase 3 MAIA study

Philippe Moreau, Thierry Facon, Shaji Kumar, Torben Plesner, Robert Z Orlowski, Nizar Bahlis, Supratik Basu, Hareth Nahi, Cyrille Hulin, Hang Quach, Hartmut Goldschmidt, Michael O’Dwyer, Aurore Perrot, Christopher Venner, Katja Weisel, Joseph R Mace, Noopur Raje, Mourad Tiab, Margaret Macro, Laurent Frenzel Show all

Clinical Lymphoma Myeloma and Leukemia | Elsevier BV | Published : 2021